Semble Secures $15 Million to Expand HealthTech Platform
Semble, an innovative healthtech company based in London, UK, has recently announced the successful completion of a $15 million Series B funding round. This fundraising initiative was spearheaded by Mercia Ventures, with significant contributions from other notable investors, including Octopus Ventures, Smedvig Ventures, and Triple Point. The injection of capital will be strategically utilized to fuel the ongoing development and expansion of Semble's integrated clinical system. The company has ambitious plans to broaden its reach within the UK market and make inroads into France, aiming to enhance its platform's capabilities and overall user experience.
Founded by the visionary duo Christoph Lippuner and Mikael Landau, Semble has established itself as a pioneer in providing integrated clinical systems tailored for healthcare businesses of all sizes.
The platform not only simplifies and streamlines various workflows but also provides valuable insights designed to improve both patient and business outcomes. This comprehensive approach positions Semble as a vital resource for healthcare practitioners, facilitating more efficient operations and ultimately better care delivery.
Since its inception, Semble has seen remarkable adoption of its platform, with over 10,000 healthcare professionals utilizing its services across the UK and France. The system supports a diverse range of over 70 medical specialties, showcasing its versatility and the team's commitment to addressing the varied needs of healthcare providers. As the company pushes forward with its growth plans, it remains focused on ensuring that its integrated clinical system continues to adapt and evolve in response to the dynamic healthcare landscape.
They've invested in Semble
Get to know these Healthtech investors
Click here for a full list of 6,528+ startup investors in the UK